Read + Share
Hauser RA, Barkay H, Fernandez HH, Jimenez-Shahed J, et al. Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of
Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of
the 3-Year, Open-Label Extension Study. J Clin Psychopharmacol 2024;44:386-396.
PMID: 38901008
|
 |
|
